Treatment

Promising Phase 3 Results for Icotrokinra: A New Oral Treatment Option

Johnson & Johnson announced promising results from its Phase 3 clinical trials for icotrokinra (JNJ-2113), an investigational oral peptide for moderate-to-severe plaque psoriasis (PsO)....

CURATED BY: Renee Ott,
MSN, CNP

Renee Ott,

MSN, CNP
Family Nurse Practitioner, Dermatologists of Central States

Fastest Time to Meaningful Clinical Response for Plaque Psoriasis

Various systemic therapies are available for the treatment of plaque psoriasis, each with distinct mechanisms of action....

Renee Ott,

MSN, CNP
Family Nurse Practitioner, Dermatologists of Central States

CURATED BY:
Renee Ott,
MSN, CNP

Roflumilast Foam 0.3% Reduces Psoriasis-Related Itch

Roflumilast foam 0.3%, a non-steroidal PDE4 inhibitor, has shown significant promise for treating psoriasis in adults and adolescents aged 12...

Alison Kortz,

PA-C
Physician Associate, Upstate Dermatology

CURATED BY:
Alison Kortz,
PA-C

A Once-Daily Patch for Psoriasis

Researchers at the University of Copenhagen have developed a patch designed to make psoriasis treatment easier and more effective....

Alison Kortz,

PA-C
Physician Associate, Upstate Dermatology

CURATED BY:
Alison Kortz,
PA-C

Bimekizumab Shows Low Risk of Suicidal Ideation and Depression in Psoriasis Patients

Patients with psoriasis have an increased risk of suicidal ideation and behavior (SIB) and depression. Bimekizumab, an interleukin (IL)-17A and...

Renee Ott,

MSN, CNP
Family Nurse Practitioner, Dermatologists of Central States

CURATED BY:
Renee Ott,
MSN, CNP

Study Highlights Psoriasis in Special Body Areas and Increased Use of Biologics With Multiple Areas Involved

Researchers of a recent study examined psoriasis in special body areas, such as the scalp, palmoplantar, genitals, and nails. The...

Alison Kortz,

PA-C
Physician Associate, Upstate Dermatology

CURATED BY:
Alison Kortz,
PA-C

Managing Psoriasis in Older Patients: Balancing Treatment Efficacy and Increased Risks

Psoriasis treatments for patients of all ages often include topicals, phototherapy, oral agents like methotrexate and cyclosporine, new oral inhibitors,...

Renee Ott,

MSN, CNP
Family Nurse Practitioner, Dermatologists of Central States

CURATED BY:
Renee Ott,
MSN, CNP

Treatment

Promising Phase 3 Results for Icotrokinra: A New Oral Treatment Option

Renee Ott,

Fastest Time to Meaningful Clinical Response for Plaque Psoriasis

Renee Ott,

Roflumilast Foam 0.3% Reduces Psoriasis-Related Itch

Alison Kortz,

A Once-Daily Patch for Psoriasis

Alison Kortz,

Bimekizumab Shows Low Risk of Suicidal Ideation and Depression in Psoriasis Patients

Renee Ott,

Study Highlights Psoriasis in Special Body Areas and Increased Use of Biologics With Multiple Areas Involved

Alison Kortz,

Managing Psoriasis in Older Patients: Balancing Treatment Efficacy and Increased Risks

Renee Ott,

© 2025 POCN—an IQVIA business. All Rights Reserved.

Share